Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
1088
-
Total 13F shares, excl. options
-
183M
-
Shares change
-
-1.95M
-
Total reported value, excl. options
-
$50.1B
-
Value change
-
-$606M
-
Put/Call ratio
-
1.34
-
Number of buys
-
498
-
Number of sells
-
-509
-
Price
-
$273.82
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2018
1,256 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q1 2018.
BIOGEN INC. - Common Stock (BIIB) has 1,088 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 183M shares
.
Largest 10 shareholders include BlackRock Inc. (17.3M shares), VANGUARD GROUP INC (15.1M shares), PRIMECAP MANAGEMENT CO/CA/ (15M shares), Clearbridge Investments, LLC (9.19M shares), STATE STREET CORP (8.75M shares), FMR LLC (6.77M shares), WELLINGTON MANAGEMENT GROUP LLP (5.07M shares), ALLIANCEBERNSTEIN L.P. (4.02M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.02M shares), and Invesco Ltd. (3.56M shares).
This table shows the top 1088 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.